Teva Pharmaceutical Industries Limited Share Price TEL AVIV STOCK EXCHANGE
Stocks
TEVA
IL0006290147
Pharmaceuticals
OTC Markets Traded|
Market Closed -
TEL AVIV STOCK EXCHANGE
11:44:58 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 10,960.00 ILa | -0.36% |
|
-0.63% | +8.62% |
| 09-04 | S&P Global Ratings Upgrades Teva Pharmaceutical to 'BBB-' | MT |
| 09-03 | Vaxcyte Names New Medical and Legal Chiefs Ahead of Key Phase 3 Data | MT |
| Market Cap | 42.37B 0 36.46B 34.3B 31.34B 58.62B 4,000B 58.78B 405B 157B 2,052B 159B 156B 6,612B | P/E 2026 * |
48.8x | P/E 2027 * | 20x |
|---|---|---|---|---|---|
| Enterprise Value | 54.27B 0 46.7B 43.94B 40.14B 75.09B 5,124B 75.29B 519B 201B 2,629B 204B 199B 8,470B | EV / Sales 2026 * |
3.27x | EV / Sales 2027 * | 2.95x |
| Free-Float |
88.59% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
TEL AVIV STOCK EXCHANGE
| TEVA | Delayed | |
OTC Markets
| TEVJF | Delayed |
Last Transcript : Teva Pharmaceutical Industries Limited
| 1 day | -0.36% | ||
| 1 week | -0.63% | ||
| Current month | +2.33% | ||
| 1 month | +5.89% | ||
| 3 months | +11.05% | ||
| 6 months | +8.95% | ||
| Current year | +8.62% |
| 1 week | 10,660 |  | 11,530 |
| 1 month | 10,290 | | 11,530 |
| Current year | 8,860 | | 11,530 |
| 1 year | 6,082 | | 11,530 |
| 3 years | 3,250 | | 11,530 |
| 5 years | 2,383 | | 11,530 |
| 10 years | 2,175 | | 19,900 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 31/12/2022 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 21/12/2019 |
Matthew Shields
COO | Chief Operating Officer | 52 | 02/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 31/12/2008 |
Sol Barer
CHM | Chairman | 78 | 05/02/2017 |
Rosemary Crane
BRD | Director/Board Member | 65 | 31/08/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.36% | -0.63% | - | - | 42.37B | |
| -0.88% | -2.15% | +54.71% | +106.31% | 1,024B | |
| -1.15% | +2.68% | +53.97% | +71.50% | 663B | |
| -1.44% | +0.38% | +20.40% | +73.05% | 453B | |
| +0.14% | -0.47% | +29.49% | +38.56% | 352B | |
| -1.33% | +4.72% | +24.69% | +45.55% | 304B | |
| -1.15% | +0.30% | -1.49% | +12.31% | 252B | |
| -1.55% | +1.11% | +56.10% | +70.32% | 236B | |
| -0.88% | +1.15% | -17.09% | -54.39% | 206B | |
| -0.15% | +3.65% | +33.90% | +96.99% | 187B | |
| Average | -0.93% | +1.09% | +28.30% | +51.13% | 408.71B | |
| Weighted average by Cap. | -1.09% | +0.55% | +36.62% | +66.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.59B 0 14.28B 13.43B 12.27B 22.95B 1,566B 23.02B 159B 61.59B 804B 62.3B 60.94B 2,589B | 17.3B 0 14.89B 14.01B 12.8B 23.94B 1,634B 24.01B 166B 64.24B 838B 64.98B 63.56B 2,701B |
| Net income | 1.44B 0 1.24B 1.17B 1.07B 1.99B 136B 2B 13.79B 5.35B 69.81B 5.41B 5.29B 225B | 2.69B 0 2.31B 2.18B 1.99B 3.72B 254B 3.73B 25.72B 9.98B 130B 10.1B 9.88B 420B |
| Net Debt | 11.9B 0 10.24B 9.64B 8.8B 16.47B 1,124B 16.51B 114B 44.19B 577B 44.7B 43.72B 1,857B | 8.65B 0 7.45B 7B 6.4B 11.97B 817B 12B 82.78B 32.12B 419B 32.49B 31.78B 1,350B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | ILA 10,960.00 | -0.36% | 473,654 |
| 03/09/26 | ILA 11,000.00 | -0.09% | 983,311 |
| 02/09/26 | ILA 11,010.00 | -0.09% | 1,791,302 |
| 01/09/26 | ILA 11,020.00 | +2.89% | 1,141,409 |
| 31/08/26 | ILA 10,710.00 | -2.90% | 905,060 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TEVA Stock
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions
